Buprenorphine Hcl Tablet
Product Images NDC 70518-2014

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 70518-2014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 8mg 70518 2014 01

Label for Buprenorphine sublingual tablets, 8 mg strength, packaged in a quantity of 60 tablets. The label includes NDC 70518-2014-01, indicates the drug is Schedule C-III, and is labeled for prescription use only. Manufactured by Hikma Pharmaceuticals USA, repackaged by RemedyRepack Inc., with storage and caution instructions included.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Buprenorphine sublingual tablets, 8 mg strength, with a quantity of 30 tablets. The label indicates the drug is Schedule III (C-III), prescription only, repackaged by RemedyRepack Inc. It includes manufacturer information for Hikma Pharmaceuticals USA Inc. and cautions about keeping medication out of reach of children and federal restrictions on transfer.*

FDA Label Image

Bup HCl Chem Fig

Chemical structure of Buprenorphine hydrochloride, showing its molecular arrangement with distinct functional groups and bonds.*

FDA Label Image

Ifu Image

An instructional illustration showing a person placing a sublingual tablet under their tongue, demonstrating the proper administration method for buprenorphine HCl tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.